Rutten, Lucy
Swart, Maarten
Koornneef, Annemart
Bouchier, Pascale
Blokland, Sven
Sadi, Ava
Juraszek, Jarek
Vijayan, Aneesh
Schmit-Tillemans, Sonja
Verspuij, Johan
Choi, Ying
Daal, Chenandly E.
Perkasa, Aditya
Torres Morales, Shessy
Myeni, Sebenzile K.
Kikkert, Marjolein
Tolboom, Jeroen
van Manen, Daniƫlle
Kuipers, Harmjan
Schuitemaker, Hanneke
Zahn, Roland
Langedijk, Johannes P. M.
Funding for this research was provided by:
Janssen Vaccines and Prevention
Article History
Received: 13 November 2023
Accepted: 5 March 2024
First Online: 8 March 2024
Competing interests
: These studies were funded by Janssen Vaccines and Prevention. L.R., M.S., A.K., P.B, S.B., A.S. J.J, A.V., S.S.T., J.V., Y.C., C.D., A.P, J.T., D.v.M., H.K., H.S., R.Z. and J.P.M.L. are employees at Janssen Vaccines and Prevention. L.R., J.J. and J.P.M.L. are inventors on an international patent application describing Trimer Stabilizing SARS-CoV-2 Spike mutations. The remaining authors declare no competing financial interests.